The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 154: ASCO GU 2022 MAGNITUDE trial of niraparib and abiraterone in metastatic CRPC
30 minutes
Posted Feb 17, 2022 at 10:40 pm.
0:00
30:32
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Kim Chi describes the results of this randomised phase 3 study.
Previous
Episode 155: ASCO GU 2022 ARASENS trial of darolutamide plus chemo vs chemo alone in hormone sensitive advanced prostate cancer
Next
Episode 157: ASCO GU 2022 Sasatuzimab and pembrolizumab in bladder cancer
← See all 501 episodes of The Uromigos